Breast Cancer Clinical Trial

Avoiding Low-value Treatments in Older Women With Early-stage Breast Cancer: Piloting a Patient Decision Aid

Summary

The aim of this study is to learn whether participants find a patient guide to breast cancer treatment decisions acceptable and appropriate for use.

View Full Description

Full Description

This study seeks to adapt and pilot test de-implementation strategies targeting low-value breast cancer treatments which have persisted despite national recommendations. Breast cancer is an ideal setting in which to study de-implementation given it is common, well-studied, typically presents at an early-stage, and care is provided primarily in a community setting.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria

Early stage breast cancer that is hormone receptor positive (HR+) and human epidermal growth factor negative (HER2-)
Meet criteria for omission of sentinel lymph node biopsy (SLNB)
Receiving care at Michigan Medicine

Exclusion Criteria

Non-English speaking
Male patients (current data does not support omission of SLNB in men)

Study is for people with:

Breast Cancer

Estimated Enrollment:

22

Study ID:

NCT05140252

Recruitment Status:

Completed

Sponsor:

University of Michigan Rogel Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Michigan Rogel Cancer Center
Ann Arbor Michigan, 48109, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

22

Study ID:

NCT05140252

Recruitment Status:

Completed

Sponsor:


University of Michigan Rogel Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.